This Pot Stock Is A Trojan Horse For Prohibitionists

Steer clear of this one.

By
Jeff Siegel

As reported by the Associated Press, the CEO of INSYS Therapeutics (NASDAQ: INSY) has been accused of giving doctors kickbacks to prescribe opioids. Not surprising at all, coming from a company that spent a half million dollars to fund an anti-legalization campaign in Arizona, and now, there’s no denying it: its stock is a trojan horse for prohibitionists.

INSYS—Why Some Consider It A Pot Stock

INSYS started to make the rounds a few years ago when investors starting getting giddy over cannabis stocks. 

You see, the company produces a synthetic cannabis drug called Syndros.  And because most analysts couldn’t really give a shit about the socially-responsible benefits that come with investing in cannabis companies (ending the War on Drugs, allowing sick people to get their medicine, etc.), the company was lumped into the basket of “cannabis stocks.”

INSYS is NOT a cannabis company. 

It’s a pharmaceutical company run by a guy who would love nothing more than to see cannabis remain illegal. After all, that would be good for business.

While this behavior doesn’t surprise me at all, it still blows my mind that the Horizons Marijuana Life Sciences ETF (TSX: HMMJ) includes INSYS as a key holding, representing 11 percent of its total holdings. If I were an HMMJ shareholder, I’d be on the phone, demanding some answers. 

If you are an HMMJ shareholder, I would suggest you do just that.

In an effort to end the War on Drugs and help our vets get access to cannabis to help treat their PTSD symptoms, it’s beyond offensive for HMMJ to include INSYS in its portfolio. Hell, just in an effort to maintain some credibility, I’d love to see HMMJ also consider the possibility that INSYS has contributed to the opioid epidemic.

Final Hit: This Pot Stock Is A Trojan Horse For Prohibitionists

Bottom line: I don’t know a single cannabis investor who would ever invest directly in a company like INSYS, yet many have by way of the HMMJ ETF. Without a doubt, this pot stock is a trojan horse for prohibitionists.

While my intention here is not to trash talk HMMJ (although I call bullshit on the Scotts Miracle-Gro holding, too), those who invest in cannabis stocks through HMMJ as a way to not only make a few bucks, but also to end the vile, racist, trillion-dollar War on Drugs, should know that some of their hard-earned cash is helping to support a bunch of shithead prohibitionists who would love nothing more than to see this war continue for another 50 years.

The only bright side is that the stock has been getting crushed …

Jeff Siegel

Jeff Siegel's been active in the financial publishing business since the mid-90s. A true capitalist, Jeff has made his fortune in what's known as socially-responsible investing, focusing primarily on alternative energy and transportation markets, sustainability, legal cannabis, and agriculture. He's a regular on the conference circuit, and every now and then you might find him appearing on Fox, CNBC, or Bloomberg. From 1994 to 2001, Jeff worked for Agora Publishing, one of the largest financial newsletter publishers in the world, before packing his bags and traveling across the globe in search of mega-trends and his own version of nirvana... He found both in the world of "green" markets. Jeff's early analyses of alternative energy and socially-responsible investing drew much criticism from the status quo. His unapologetic capitalist spirit, and abrasive nature didn't earn him many accolades from colleagues, either... But after accurately predicting dozens of trends in the ever-changing landscape of "green" market investing, many have since traded their preconceptions of socially-responsible investing for profits. Often declaring, “Capitalism is a catalyst for positive change,” Jeff continues to spot the most lucrative renewable energy, organic food and cannabis companies in the world. And his thousands of loyal readers have made small fortunes in the process. Each week, Jeff shares the latest in "green" market news as well as his own market updates and recommendations. Jeff also works as a consultant, has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling energy book, Investing in Renewable Energy: Making Money on Green Chip Stocks and is the co-author of Energy Investing for Dummies. http://www.wealthdaily.com/editors/jeff-siegel

By
Jeff Siegel

Recent Posts

Twenty-One of 27 European Union Countries Legalized Medical Cannabis, Report Highlights

Biortica Agrimed released an assessment of the state of medical cannabis and decriminalization laws in…

1 hour ago

Gifting Parties in Connecticut Can Continue with Limits Under Settlement with Attorney General

Attorney General William Tong arrived at a settlement over gifting parties with HighBazaar in Connecticut.

1 hour ago

DEA Report Reflects Average Potency of THC in Illegal Cannabis at 16%

The DEA’s report assesses the status of a variety of federally illegal substances, including fentanyl,…

1 hour ago

The Weirdos State of the Union

To celebrate the second birthday of WEIRDOS, our VP of Content waxes on the year…

1 hour ago

New Study Analyzes the Effects of THCV, CBD on Weight Loss

Study participants were given doses of THCV/CBD or a placebo in order for researchers to…

1 hour ago

President Biden Announces Federal Government Will Reschedule Cannabis in ‘Monumental’ Announcement

It’s official: The U.S. Department of Justice will reschedule cannabis, moving it to Schedule III,…

16 hours ago